Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Shares of Wegovy Partner Catalent Jump After Striking Deal With Activist Investor Elliott
Investopedia
Wed, 08/30/23 - 10:03 am
Catalent
Wegovy
Novo Nordisk
Elliott Management
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
Why Wegovy's Sales Potential Could Be Massively Understated
Motley Fool
Tue, 08/29/23 - 11:08 am
Novo Nordisk
Wegovy
heart attack
stroke
Novo Nordisk set to launch weight loss drugs in more countries but in constrained fashion, CEO says
Fierce Pharma
Mon, 08/28/23 - 08:00 pm
Novo Nordisk
weight loss
Wegovy
Ozempic
On a roll, Novo's star obesity drug Wegovy shows benefits in patients with heart failure
Fierce Pharma
Fri, 08/25/23 - 11:54 am
Novo Nordisk
Wegovy
heart failure
clinical trials
Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO Says
Forbes
Fri, 08/25/23 - 09:48 am
Novo Nordisk
Wegovy
Lars Fruergaard Jorgensen
weight loss
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
Motley Fool
Thu, 08/24/23 - 09:50 pm
Novo Nordisk
Ozempic
diabetes
weight loss
liver disease
addiction
cardiovascular disease
Novo Nordisk enlists Thermo Fisher as second Wegovy manufacturer: report
Medical Marketing and Media
Wed, 08/23/23 - 05:38 pm
Novo Nordisk
Thermo Fisher
drug manufacturing
Wegovy
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Yahoo/Zacks.com
Tue, 08/22/23 - 09:58 am
earnings
Eli Lilly
JNJ
Novo Nordisk
Novartis
AstraZeneca
Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print
Forbes
Mon, 08/21/23 - 10:38 am
weight loss
Novo Nordisk
Wegovy
Ozempic
Demand for weight loss drugs soars to nearly half of Americans
Pharma Voice
Wed, 08/16/23 - 10:14 am
weight loss
Novo Nordisk
Ozempic
Obesity, diabetes drugs push Novo Nordisk and Eli Lilly to front of pharma's growth pack in Q2
Fierce Pharma
Wed, 08/16/23 - 10:05 am
Novo Nordisk
Eli Lilly
obesity
diabetes
earnings
Novo Nordisk prolongs rationing Wegovy solutions
Beckers Hospital Review
Thu, 08/10/23 - 09:59 pm
Novo Nordisk
Wegovy
drug rationing
drug shortages
Novo Nordisk bets $1.1B on Canadian biotech buyout, adding an old approach to obesity pipeline
Fierce Biotech
Thu, 08/10/23 - 11:41 am
Novo Nordisk
M&A
obesity
Inversago
In the era of blockbuster obesity drugs, a personalized approach could boost outcomes
Pharma Voice
Wed, 08/9/23 - 10:14 am
obesity
Phenomix
Novo Nordisk
Ozempic
Wegovy
Novo Nordisk posts 'best-case scenario' cardio outcomes data for star obesity drug Wegovy
Fierce Pharma
Tue, 08/8/23 - 11:25 am
Novo Nordisk
Wegovy
clinical trials
cardiovascular disease
obesity
Report: Fewer Adults Are Interested in Weight Loss Drugs If Not Covered by Insurance
MedCity News
Mon, 08/7/23 - 11:12 pm
insurance
weight loss
payers
Novo Nordisk
Eli Lilly
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
Novo Nordisk, Eli Lilly face injury lawsuit from user of popular GLP-1 medicines
Fierce Pharma
Thu, 08/3/23 - 06:44 pm
Novo Nordisk
Eli Lilly
Mounjaro
Ozempic
legal
side effects
Spotlight – Nash in 2023 and beyond
EP Vantage
Thu, 08/3/23 - 10:03 am
NASH
Boehringer Ingelheim
Zealand Pharma
Akero Therapeutics
Axcella Health
Eli Lilly
Pfizer
Ionis Pharmaceuticals
Cascade
AstraZeneca
Gilead Sciences
Novo Nordisk
Ascletis Pharma
MediciNova
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »